Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.8 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.7 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.90 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.58 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.98 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.65 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.466EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
L.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.339EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.229EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used